Germany· DE-A57-b9ca852399ce75b3
Isoprotrace
A medicinal product containing gozetotide, registered in Germany by Billev Pharma Aps.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Gozetotide
- Manufacturer
- Billev Pharma Aps
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gozetotide in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaILLUCCIXTelix Innovations, Herstal
- BelgiumIlluccix 25 µgTelix Innovations
- FinlandIlluccixTelix Innovations
- SwedenIlluccix 25 mikrogram Beredningssats för radioaktivt läkemedelTelix Innovations
- NetherlandsIlluccix 25 microgram kit voor radiofarmaceutisch preparaatTelix Innovations S.A.
- United StatesLOCAMETZNovartis Pharmaceuticals Corporation
- FranceILLUCCIX 25 microgrammes, trousse pour préparation radiopharmaceutiqueTELIX INNOVATIONS (BELGIQUE)
- United KingdomIlluccix 25microgram kit for radiopharmaceutical preparationXiel Ltd
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Illuccix, Isoprotrace
- Belgium · Illuccix, Isoprotrace
- Cyprus · Illuccix, Isoprotrace
- Czechia · Illuccix, Isoprotrace
- Denmark · Illuccix, Isoprotrace
- Spain · Illuccix, Isoprotrace
- Finland · Illuccix, Isoprotrace
- France · Illuccix, Isoprotrace
- United Kingdom (Northern Ireland) · Illuccix, Isoprotrace
- Greece · Illuccix, Isoprotrace
- Ireland · Illuccix
- Iceland · Locametz
- Italy · Illuccix, Viewprost
- Liechtenstein · Locametz
- Luxembourg · Illuccix, Isoprotrace
- Malta · Illuccix, Isoprotrace
- Netherlands · Illuccix, Isoprotrace
- Norway · Illuccix, Isoprotrace
- Poland · Psmatrace
- Portugal · Illuccix, Isoprotrace
- Sweden · Illuccix, Isoprotrace
- Slovakia · Illuccix, Isoprotrace
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ca8c026a-2139-4bde-b8a3-fb7ab78aa697 GET /v1/drugs/ca8c026a-2139-4bde-b8a3-fb7ab78aa697?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Gozetotide",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about gozetotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.